Nuclear Medicine

Doç. Dr. Handan Tokmak

Doctor and researcher İstanbul Prof. Dr. Cemil Taşcıoğlu Şehir Hastanesi İstanbul
Rectal NeoplasmsFever of Unknown Origin
Open institution page
Suggest a correction

Is this your profile? Claim it and verify your details.

Claim profile

Person ↔ Disease

Which diseases does this doctor work on?

From source
  • Rectal Neoplasms 7 publications
    Source: OpenAlex / PubMed MeSHView publications
  • Fever of Unknown Origin 2 publications

Trust

Where does this information come from?

The source is stated next to each piece of information. If you see something wrong, you can suggest a correction.

  • SpecialtyNuclear Medicinesaglik.gov.trFrom source
  • Institutionİstanbul Prof. Dr. Cemil Taşcıoğlu Şehir Hastanesisaglik.gov.trFrom source
  • Area of workRectal NeoplasmsExtracted from 7 publications · Model version —From source
  • Publications48 publicationsORCIDFrom source
  • ORCID0000-0002-7662-4325ORCIDFrom source
  • Last synchronised5 November 2026 08:55https://cemiltascioglush.saglik.gov.tr/TR-1563433/doktorlarimiz.html#handan-tokmaksaglik.gov.tr

Scientific work

Publications on Rectal Neoplasms

48 publications

  1. Total Lesion Glycolysis (TLG) on 18F-FDG PET/CT as a Potential Predictor of Pathological Complete Response in Locally Advanced Rectal Cancer After Total Neoadjuvant Therapy: A Retrospective Study

    Diagnostics, 2025

    DOI 10.3390/diagnostics15141800 PMID 40722549 3 citations (Europe PMC) Open-access full textSource: ORCID

  2. Outcomes of watch and wait after short-course radiotherapy in an international multicentre watch-and-wait cohort.

    The British journal of surgery, 2024

    DOI 10.1093/bjs/znae242 PMID 39392106 5 citations (Europe PMC) Open-access full textSource: ORCID

  3. Watch and wait after neoadjuvant treatment in rectal cancer: comparison of outcomes in patients with and without a complete response at first reassessment in the International Watch & Wait Database (IWWD)

    The British journal of surgery, 2023

    DOI 10.1093/bjs/znad051 PMID 36972213 50 citations (Europe PMC) Open-access full textSource: ORCID

  4. Intracavitary Radionuclide Applications

    Radionuclide Therapy, 2022

    Source: ORCID

  5. Intracavitary Radionuclide Applications

    Radionuclide Therapy, 2022

    DOI 10.1007/978-3-030-97220-2_22 Source: ORCID

  6. Radionuclide Therapy

    Radionuclide Therapy, 2022

    DOI 10.1007/978-3-030-97220-2 1 citation (OpenAlex) Source: ORCID

  7. Robotic versus laparoscopic sphincter-saving total mesorectal excision for mid or low rectal cancer in male patients after neoadjuvant chemoradiation therapy: comparison of long-term outcomes

    Journal of Robotic Surgery, 2020

    DOI 10.1007/s11701-019-01001-5 PMID 31313071 22 citations (Europe PMC) Source: ORCID

  8. The long-term oncological outcomes of the 140 robotic sphincter-saving total mesorectal excision for rectal cancer: a single surgeon experience

    Journal of Robotic Surgery, 2020

    DOI 10.1007/s11701-019-01037-7 PMID 31811567 13 citations (Europe PMC) Source: ORCID

  9. Robotic Sphincter-Saving Total Mesorectal Excision for Rectal Cancer Treatment: A Single-Surgeon Experience in 103 Consecutive Male Patients.

    Surgical technology international, 2020

    PMID 32634247 13 citations (Europe PMC) Source: ORCID

  10. Predictive Value of 18F-FDG PET-CT pCR In Locally Advanced Rectal Cancer After Total Neoadjuvant Chemoradiotherapy

    European Journal of Surgical Oncology (EJSO), 2020

    DOI 10.1016/j.ejso.2019.11.254 Source: ORCID

View all 48 publications